Back to results

Completed

Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients

NCT02588859

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Nellure, Andhra Pradesh, India

+30 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2015-10-30
Enrollment: 1,200 participants
Sponsor: AstraZeneca

Locations (31)

Research SiteNellure, Andhra Pradesh, India
Research SiteVisakhapatnam, Andhra Pradesh, India
Research SiteGuwahati, Assam, India
Research SiteAhmedabad, Gujarat, India
Research SiteRajkot, Gujarat, India
Research SiteVadodara, Gujarat, India
Research SiteKarnāl, Haryana, India
Research SiteYamuna Nagar, Haryana, India
Research SiteBangalore, Karnataka, India
Research SiteTrivandrum, Kerala, India
Research SiteKochi, Kochi, India
Research SiteBhopal, Madhya Pradesh, India
Research SiteIndore, Madhya Pradesh, India
Research SiteMumbai, Maharashtra, India
Research SitePune, Maharashtra, India
Research SiteNew Delhi, National Capital Territory of Delhi, India
Research SiteAmritsar, Punjab, India
Research SiteChandigarh, Punjab, India
Research SiteLudhiana, Punjab, India
Research SiteJaipur, Rajasthan, India
Research SiteUdaipur, Rajasthan, India
Research SiteChennai, Tamil Nadu, India
Research SiteMadurai, Tamiladu, India
Research SiteHyderabad, Telangana, India
Research SiteHyderebad, Telangana, India
Research SiteAllahābād, Uttar Pradesh, India
Research SiteKanpur, Uttar Pradesh, India
Research SiteLucknow, Uttar Pradesh, India
Research SiteNoida, Uttar Pradesh, India
Research SiteKolkata, West Bengal, India
Research SiteNew Delhi, India

Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients — TrialFind